QA: Vyant Bio Inc in us_health_services/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001349929_2021_Vyant_Bio_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.12307589791430666, 'aggregate_val': 16854000, 'exp_sum': 15007000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 0, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 8424000, 'ResearchAndDevelopmentExpense': 4273000, 'remainder_Expenses': 2310000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.27703715087018327, 'aggregate_val': 37636000, 'exp_sum': 52058000, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 14422000, 'AssetsCurrent': 23214000, 'PropertyPlantAndEquipment': 1020000, 'remainder_Assets': 13402000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.31241248661560006, 'aggregate_val': 8348000, 'exp_sum': 12141000, 'exp_to_value': {'IntangibleAssets': 2977000, 'AssetsNonCurrent': 3793000, 'AssetsCurrent': 4107000, 'PropertyPlantAndEquipment': 448000, 'remainder_Assets': 816000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001349929')"}

Graph

Absolute values for 0001349929, Vyant Bio Inc

  xvar xval
0 IntangibleAssets 2,977,000
1 AssetsNonCurrent 3,793,000
2 AssetsCurrent 4,107,000
3 PropertyPlantAndEquipment 448,000
4 remainder_Assets -2,977,000
5 LongTermLiabilities 32,000
6 LiabilitiesCurrent 4,263,000
7 remainder_Liabilities 73,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 3,353,000
10 GeneralAndAdministrativeExpense 6,595,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 1,246,000
15 ResearchAndDevelopmentExpense 0
16 remainder_Expenses 2,740,000
17 remainder_Revenues 5,751,000
18 remainder_NetIncome 182,000
19 remainder_ComprehensiveNetIncome -249,000
  yvar yval
0 Assets 8,348,000
1 Liabilities 4,368,000
2 Expenses 13,934,000
3 Revenues 5,751,000
4 StockholdersEquity 3,980,000
5 NetIncome -8,001,000
6 ComprehensiveNetIncome -8,250,000
7 BaseVar 16,416,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.390
9 EconomicCapitalRatio 0.847

Edgar->Model Mapping

Feature Distribution

Change over Time